World Diabetes & Endocrinology Conference
World Diabetes & Endocrinology Conference
National Institute of Diabetes and Digestive and Kidney Diseases
USA
Jürgen Wess, Ph.D., is the Chief of the Molecular
Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland,
USA. He received his Ph.D. in Pharmacology from the Goethe University in
Frankfurt/Main (Germany) and subsequently worked as a Postdoctoral Fellow at
the National Institute of Mental Health (NIMH) and the National Institute of
Neurological Disorders and Stroke (NINDS), NIH, Bethesda, Maryland, USA. Dr.
Wess is a pharmacologist with primary interest in the general area of G
protein-coupled receptors (GPCRs). During the past three decades, he has
generated and analyzed a very large number of sophisticated mutant mouse models
to learn more about the physiological and pathophysiological roles of specific
GPCRs and downstream signaling pathways. More recently, Dr. Wess also started
to explore the metabolic roles of the two beta-arrestins by phenotyping cell
type-specific beta-arrestin mutant mice. He has published more than 300
peer-reviewed journal articles in numerous scientific journals including
Nature, Neuron, and Cell Metabolism (h index: 91). Dr. Wess is a regular
speaker at the top meetings in his field including Gordon and Keystones
Conferences and has received many prestigious awards. The major goal of his research
is to identify GPCRs or GPCR-linked signaling pathways that can be targeted for
the treatment of diabetes and obesity.